Page 101 - ITPS-7-4

INNOSC Theranostics and
Pharmacological Sciences LMWH for VTE prophylaxis in acute stroke patients

29. Lewis BE, Wallis DE, Leya F, Hursting MJ, Kelton JG, ischaemic stroke. Lancet. 1997;349(9065):1569-1581.
Argatroban-915 Investigators. Argatroban anticoagulation doi: 10.1016/S0140-6736(97)04011-7
in patients with heparin-induced thrombocytopenia. Arch
Intern Med. 2003;163(15):1849-1856. 32. Wong KS, Chen C, Ng PW, et al. Low-molecular-weight
heparin compared with aspirin for the treatment of acute
doi: 10.1001/archinte.163.15.1849
ischaemic stroke in Asian patients with large artery occlusive
30. LaMonte MP, Stallmeyer MB. Acute ischemic stroke disease: A randomised study. Lancet Neurol. 2007;6(5):
successfully treated using sequenced intravenous and 407-413.
intra-arterial thrombolysis and argatroban anticoagulation: doi: 10.1016/S1474-4422(07)70079-0
A case study. J Thromb Thromb. 2004;17:151-156.
33. National Clinical Guidance for Stroke. Deep vein thrombosis
doi: 10.1023/B: THRO.0000037672.43462.d5
and Pulmonary Embolism. p. 60; 2023. Available from:
31. Sandercock P, Collins R, Counsell C, et al. The International https://www.strokeguideline.org/app/uploads/2023/04/
Stroke Trial (IST): A randomised trial of aspirin, subcutaneous National-Clinical-Guideline-for-Stroke-2023.pdf [Last
heparin, both, or neither among 19 435 patients with acute accessed on 2024 Oct 02].

Volume 7 Issue 4 (2024) 8 doi: 10.36922/itps.3250